Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
- PMID: 12829775
- DOI: 10.1126/science.1083182
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
Abstract
Human antibody 2G12 neutralizes a broad range of human immunodeficiency virus type 1 (HIV-1) isolates by binding an unusually dense cluster of carbohydrate moieties on the "silent" face of the gp120 envelope glycoprotein. Crystal structures of Fab 2G12 and its complexes with the disaccharide Manalpha1-2Man and with the oligosaccharide Man9GlcNAc2 revealed that two Fabs assemble into an interlocked VH domain-swapped dimer. Further biochemical, biophysical, and mutagenesis data strongly support a Fab-dimerized antibody as the prevalent form that recognizes gp120. The extraordinary configuration of this antibody provides an extended surface, with newly described binding sites, for multivalent interaction with a conserved cluster of oligomannose type sugars on the surface of gp120. The unique interdigitation of Fab domains within an antibody uncovers a previously unappreciated mechanism for high-affinity recognition of carbohydrate or other repeating epitopes on cell or microbial surfaces.
Similar articles
-
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.Science. 2011 Nov 25;334(6059):1097-103. doi: 10.1126/science.1213256. Epub 2011 Oct 13. Science. 2011. PMID: 21998254 Free PMC article.
-
A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands.Chemistry. 2011 Feb 1;17(5):1547-60. doi: 10.1002/chem.201002519. Epub 2011 Jan 5. Chemistry. 2011. PMID: 21268157
-
Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design.Chem Biol. 2004 Jan;11(1):127-34. doi: 10.1016/j.chembiol.2003.12.020. Chem Biol. 2004. PMID: 15113002
-
Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.J Mol Recognit. 1999 Jan-Feb;12(1):19-32. doi: 10.1002/(SICI)1099-1352(199901/02)12:1<19::AID-JMR445>3.0.CO;2-Y. J Mol Recognit. 1999. PMID: 10398393 Review.
-
Structural studies of human HIV-1 V3 antibodies.Hum Antibodies. 2005;14(3-4):73-80. Hum Antibodies. 2005. PMID: 16720977 Review.
Cited by
-
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env.Nat Struct Mol Biol. 2015 Jul;22(7):522-31. doi: 10.1038/nsmb.3051. Epub 2015 Jun 22. Nat Struct Mol Biol. 2015. PMID: 26098315 Free PMC article.
-
Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1.Cold Spring Harb Perspect Med. 2011 Sep;1(1):a007278. doi: 10.1101/cshperspect.a007278. Cold Spring Harb Perspect Med. 2011. PMID: 22229123 Free PMC article. Review.
-
A strategy for phage display selection of functional domain-exchanged immunoglobulin scaffolds with high affinity for glycan targets.J Immunol Methods. 2012 Feb 28;376(1-2):150-5. doi: 10.1016/j.jim.2011.12.008. Epub 2011 Dec 31. J Immunol Methods. 2012. PMID: 22233878 Free PMC article.
-
Targeting N-glycan cryptic sugar moieties for broad-spectrum virus neutralization: progress in identifying conserved molecular targets in viruses of distinct phylogenetic origins.Molecules. 2015 Mar 12;20(3):4610-22. doi: 10.3390/molecules20034610. Molecules. 2015. PMID: 25774492 Free PMC article.
-
A cross-neutralizing antibody between HIV-1 and influenza virus.PLoS Pathog. 2021 Mar 22;17(3):e1009407. doi: 10.1371/journal.ppat.1009407. eCollection 2021 Mar. PLoS Pathog. 2021. PMID: 33750987 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
